IBABB Stock Overview

Develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. More details

IBABB fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	4/6
Past Performance	3/6
Financial Health	6/6
Dividends	1/6

Rewards

Earnings are forecast to grow 46.64% per year

Earnings grew by 56.1% over the past year

Risk Analysis

Shares are highly illiquid

Large one-off items impacting financial results

My Notes

Capture your thoughts, links and company narrative

Ion Beam Applications SA Competitors

NIOX Group

AIM:NIOX

UK£232.4m

EKF Diagnostics Holdings

AIM:EKF

UK£120.2m

Smith & Nephew

LSE:SN.

UK£8.6b

Advanced Medical Solutions Group

AIM:AMS

UK£415.2m

Price History & Performance

Summary of share price highs, lows and changes for Ion Beam Applications
Historical stock prices
Current Share Price	€18.14
52 Week High	€18.60
52 Week Low	€14.36
Beta	0.76
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	124.78%
5 Year Change	-25.59%
Change since IPO	263.53%

Recent updates

Shareholder Returns

	IBABB	GB Medical Equipment	GB Market
7D	0%	1.0%	-0.3%
1Y	n/a	-10.0%	4.9%

Return vs Industry: Insufficient data to determine how IBABB performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how IBABB performed against the UK Market.

Price Volatility

Is IBABB's price volatile compared to industry and market?
IBABB volatility
IBABB Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.4%
Market Average Movement	4.8%
10% most volatile stocks in GB Market	10.8%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: IBABB has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine IBABB's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1986	1,629	Olivier Legrain	www.iba-worldwide.com

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems.

Ion Beam Applications SA Fundamentals Summary

How do Ion Beam Applications's earnings and revenue compare to its market cap?
IBABB fundamental statistics
Market cap	€477.37m
Earnings (TTM)	€6.06m
Revenue (TTM)	€361.27m

78.8x

P/E Ratio

1.3x

P/S Ratio

Is IBABB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IBABB income statement (TTM)
Revenue	€361.27m
Cost of Revenue	€234.51m
Gross Profit	€126.77m
Other Expenses	€120.71m
Earnings	€6.06m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

Aug 31, 2023

Earnings per share (EPS)	0.21
Gross Margin	35.09%
Net Profit Margin	1.68%
Debt/Equity Ratio	12.4%

How did IBABB perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

101%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/06/06 04:46
End of Day Share Price	2023/03/09 00:00
Earnings	2022/12/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ion Beam Applications SA is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Tim Heirwegh	BNP Paribas Exane
Laura Roba	Degroof Petercam
Mathew Fernley	Haitong Bank S.A.